Neutrogena Clear Pore

Quick links

Choose a section

Quick links to important sections

Advertisements

Neutrogena Clear Pore

Advertisements
Advertisements

Treatment option: Zits, Acne Vulgaris

Advertisements

Overview of Neutrogena Clear Pore

Property Description
Active ingredient Benzoyl Peroxide (BPO, typically 3.5%)
Form Cleanser/Mask (Dual-purpose Foaming Wash)
Pharmacological class Antiacne Agent, Topical Antimicrobial Agent
Common use Addressing causes of mild to moderate acne lesions
Origin Synthetic Organic Peroxide

Defining Neutrogena Clear Pore: Active Ingredient and Formulation Type

Neutrogena Clear Pore is defined as an Over-the-Counter (OTC) dermatological product belonging to the category of Topical Antiacne Preparations. Its core functionality is derived from its sole active substance, Benzoyl Peroxide (BPO), which is classified as a synthetic organic peroxide. The U.S. Food and Drug Administration (FDA) recognizes Benzoyl Peroxide as an approved active ingredient in OTC drug products for acne management.

The product is presented as a Foaming Wash that is uniquely marketed as a dual-purpose cleanser/mask. This single-ingredient product (monotherapy) is delivered via a specialized vehicle containing kaolin and bentonite clay. This combination helps facilitate oil absorption and deep pore cleansing, distinguishing the product from traditional BPO washes.


Pharmacological Class and Primary Mechanism Group

This preparation is categorized in the Antiacne Agent pharmacological class, specifically functioning as a Topical Antimicrobial Agent due to its primary action against the Cutibacterium acnes (C. acnes) bacteria. The product exerts a dual effect, providing a keratolytic action that assists in cell turnover, alongside a potent oxidative mechanism.

The unique mechanism of Benzoyl Peroxide involves the non-specific release of oxygen radicals, creating an environment hostile to the anaerobic C. acnes bacteria. Its efficacy is clinically recognized for managing acne vulgaris, with pharmacological studies supporting its role as a first-line topical treatment. The formulation often includes features like Menthol, providing a cooling sensation that differentiates the user experience.


General Purpose: What is the Main Benefit of This Preparation?

The general therapeutic purpose is to intervene in the progression of acne by targeting its root causes: bacterial overgrowth and pore blockage. By providing both a recognized antimicrobial agent and a clay-based cleanser, the preparation helps the skin maintain a clearer, less congested state. The inclusion of oil-absorbing clays supports a typical use scenario focusing on reducing excess sebum and surface shine alongside the treatment of lesions, thereby offering the primary benefit of supporting the reduction of common acne lesions.

Regulatory References

  1. DailyMed: Benzoyl Peroxide Topical Wash
Advertisements

What side effects are possible with Neutrogena Clear Pore?

Possible Side Effects and Safety Information

The official regulatory safety profile for topical Benzoyl Peroxide (the active ingredient) is largely characterized by local skin reactions at the site of application and the potential for rare, serious systemic events.

Category Description
Key Adverse Reaction Categories Local Skin and Subcutaneous Tissue Disorders; Immune System Disorders.
Frequency Classification Common reactions include skin peeling, dryness, erythema (redness), and sensations of burning or stinging. Rare or Frequency Not Known is assigned to severe, systemic hypersensitivity.
System-Organ Classes Involved Skin and Subcutaneous Tissue Disorders contain the most frequent local effects. Immune System Disorders include the potential for serious reactions.
Serious Adverse Reactions Regulatory documents list the potential for rare, severe hypersensitivity reactions, including Anaphylaxis and Angioedema (severe facial or throat swelling).
Dose- or Exposure-Related Patterns Common local reactions, such as dryness and peeling, are explicitly documented as most likely to occur during the initial weeks of treatment.

High-Level Safety Constraints

The official labeling defines specific restrictions and cautions that must be noted during use:

  • The product may increase sensitivity to sunlight (photosensitivity), and regulators advise caution regarding UV exposure.
  • It is restricted from use in individuals with a known hypersensitivity to benzoyl peroxide.
  • The product carries an official warning regarding its ability to bleach hair or colored fabrics upon contact.

Regulatory Safety Summary

  • The risk profile is structured around frequent, localized irritation that tends to be temporary and a distinct, rare risk of serious systemic hypersensitivity.
  • Safety constraints focus heavily on avoiding exposure to mucous membranes and reducing UV light exposure.
  • The profile establishes that local reactions are a documented pattern related to the initial exposure period.
Advertisements

Overdose and Emergency Response

Overdose Scope

Property Official Regulatory Statement
Documented overdose presentations Severe local skin irritation, including redness, burning, peeling, and swelling (from excessive topical use). Signs of severe, immediate hypersensitivity reactions (e.g., hives, severe itching, swelling).
Physiological systems affected Integumentary System (local irritation); Systemic/Immune System (severe hypersensitivity reactions).
Dose-related or exposure-related factors Excessive topical application; Accidental oral ingestion.
Population-specific overdose notes No specific population-based considerations concerning altered overdose severity are explicitly documented in the general labeling.
Emergency-response statements If swallowed, get medical help or contact a Poison Control Center right away.
When immediate medical help is required If irritation becomes severe, stop use and ask a doctor. Immediate medical attention is required upon signs of life-threatening systemic outcomes like trouble breathing or swelling of the face or throat.

Overdose Classifications (High-Level)

Classification Official Regulatory Statement
Severity classification Classified as Severe Local Irritation or Life-Threatening Systemic Hypersensitivity (e.g., Anaphylaxis, Angioedema).
Regulatory basis Based on U.S. NIH DailyMed and FDA Prescribing Information requirements.
Overdose-context constraints No specific antidote is known. Management is described as symptomatic and supportive treatment.

Resulting Overdose Structure

Official overdose statements:

  • Excessive topical application may result in severe skin irritation, which requires the user to stop use and ask a doctor if the irritation does not improve or is severe.
  • Accidental oral ingestion is a mandatory trigger for seeking emergency help, explicitly requiring the individual to contact a Poison Control Center right away.
  • The appearance of symptoms such as throat tightness, difficulty breathing, or swelling of the face, eyes, lips, or tongue is classified as a life-threatening systemic outcome, mandating seeking immediate emergency medical attention.

Connection to the overall overdose profile (2–4 sentences): The regulatory documents define the overdose profile primarily through two distinct emergency scenarios: the local risk from excessive topical use and the systemic risk from accidental ingestion or rare, severe hypersensitivity. Regulators mandate specific, immediate actions—ranging from consulting a doctor for severe irritation to seeking emergency medical help for systemic symptoms—to address these documented presentations. In all overdose contexts, no specific antidote is known, and the official guidance defines treatment as symptomatic and supportive.

Advertisements

Therapeutic Uses of Neutrogena Clear Pore

What Neutrogena Clear Pore Treats: Main Uses and Benefits

This preparation is commonly used across conditions characterized by mild to moderate acne vulgaris, primarily to address the manifestation of inflammatory symptoms (papules and pustules) and non-inflammatory symptoms (blackheads and whiteheads). The primary benefit may be that it helps address existing breakouts and eases the symptom burden associated with visible lesions, which supports a clearer skin appearance.

The product is relevant for easing symptoms that include visible comedones, inflammatory papules, and pus-filled pustules. It is commonly used as a topical treatment for mild to moderate acne.

Managing Excess Sebum and Preventing Pore Congestion

This dual-purpose product is relevant across domains where excessive facial sebum and pore congestion lead to recurrent breakouts, often applied in situations requiring supportive symptom management. This therapeutic focus helps provide the key benefit of shine control and supports the prevention of new lesions by addressing symptoms related to pore congestion, which may be part of symptomatic management for long-term skin maintenance.

Supportive Care for Acne-Prone and Oily Skin

Commonly used across conditions characterized by episodic or fluctuating symptom patterns, this preparation offers symptomatic assistance for acne-prone individuals and those with an oily skin type. It may contribute to easing day-to-day comfort by helping the patient cope more steadily with challenging symptomatic phases.


Quick Fact: Relief for Acne Lesions The preparation is applied in contexts marked by increased discomfort due to mild to moderate inflammatory and non-inflammatory lesions, helping to ease the overall symptom burden associated with visible spots and bumps.

Advertisements

Eligibility and Restrictions for Use

The official eligibility profile for this topical preparation is defined by specific population criteria documented in government regulatory sources. Use is generally permitted for adolescents and adults, but is strictly prohibited for certain groups and requires caution under specific conditions.

Populations for Whom Use is Prohibited

Group or Condition Regulatory Status
Known Hypersensitivity Contraindicated in individuals with a known allergy or sensitivity to Benzoyl Peroxide.
Skin State Contraindicated for use on very sensitive, broken, cut, scraped, or sunburned skin.

Age and Physiological Eligibility Status

Population Eligibility Rule
Age Permitted for individuals 12 years of age and older. Use by children younger than 12 years requires consultation with a physician.
Pregnancy / Lactation Generally acceptable for use during pregnancy and breastfeeding due to minimal systemic absorption.

Eligibility-Related Restrictions

Official labeling indicates conditional use for individuals applying other topical acne medications simultaneously, as this combination may increase skin irritation. During breastfeeding, application to the chest area must be avoided to prevent direct infant contact. The regulatory basis for these rules ensures that populations with a heightened risk of irritation or known allergy are excluded from standard use.

Advertisements

What should I know about interactions with other medicines?

The official interaction profile for this topical product, which contains Benzoyl Peroxide, is primarily defined by local pharmacodynamic and chemical incompatibilities rather than systemic interactions. Due to minimal systemic absorption, regulatory documents classify pharmacokinetic interactions with oral medicines (e.g., CYP or transporter effects) as unlikely to occur.

Interaction restrictions center on cumulative irritancy. Co-administration with other topical acne medications is associated with an increased risk of severe local reactions, such as excessive dryness, scaling, and redness. Official labeling restricts the concurrent use of irritating topical products, including abrasive cleansers, strong drying agents, and products containing high concentrations of alcohol or astringents.

A significant drug-drug interaction exists with topical retinoids (such as tretinoin and adapalene). Benzoyl Peroxide's oxidative properties can reduce the retinoid’s efficacy and concurrently worsen skin irritation. This interaction necessitates a timing-based separation, where regulatory guidance requires BPO and the retinoid to be applied at different times of the day (e.g., one in the morning and one at night).

Other documented chemical interactions include a potential for transient discoloration (yellow/orange staining) when BPO is used alongside PABA-containing sunscreens or topical sulfonamide-containing products. No population-specific interaction considerations are documented for patients with organ impairment.

Advertisements

Mechanism of Action

How Neutrogena Clear Pore Works

The preparation's effect is driven primarily by the pharmacodynamic actions of its single active component, Benzoyl Peroxide (BPO), which acts through two distinct, simultaneous mechanistic domains.


Non-Specific Oxidative Bactericidal Action

This domain addresses the interaction of BPO with the bacterium extitCutibacterium acnes ( extitC. acnes). Upon penetration into the hair follicle, BPO is metabolized into highly reactive free oxygen radicals. This mechanism initiates a sequence of events that results in the oxidative destruction of the anaerobic bacteria. The resulting reduction in the extitC. acnes population decreases the release of pro-inflammatory bacterial metabolites, which attenuates localized inflammatory signaling.


Modulation of Follicular Epithelial Turnover

This secondary domain focuses on BPO's impact on the epithelial lining of the follicle. BPO exerts a keratolytic effect that promotes the accelerated loosening and shedding (desquamation) of dead skin cells (keratinocytes). This physiological consequence reduces excessive cell cohesion and the formation of physical obstructions, supporting a regulated cellular flow within the follicle.

Advertisements

Dosage and Administration Information

The administration of the Benzoyl Peroxide 3.5% preparation is defined as topical for external use only. The usage protocol incorporates two distinct regimens—a daily cleanser pattern and an intermittent mask pattern—both subject to frequency adjustment based on local cutaneous response.

Administration Component Official Labeled Instruction
Route of Administration Topical application only.
Initial Cleanser Frequency Start with one application daily.
Maximum Mask Frequency Use as a mask must not exceed two to three times per week.
Dosing Adjustment Frequency must be reduced to once a day or every other day if bothersome drying or peeling occurs.
Pre-Application Condition The skin is required to be cleansed thoroughly before applying the product.

The labeled schedule permits the gradual escalation of the cleanser frequency to two or three times daily following the initial one-time use, provided the product is well-tolerated. Specific procedural conditions also govern use, including the requirement to leave the product on for a maximum of 5 minutes when administered as a mask. Instructions also include the subsequent application of sunscreen if the user is going outside following the use of the product. These instructions collectively define a standardized approach for using the product.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Neutrogena Clear Pore

Evidence for Use in Mild to Moderate Acne Vulgaris

The research foundation for Benzoyl Peroxide (BPO) monotherapy, the active ingredient in Neutrogena Clear Pore, was evaluated in research exploring acne vulgaris that is characterized by fluctuating or episodic manifestations. The research examining BPO includes data from Randomized Controlled Trials (RCTs) and Systematic Reviews that consolidate findings from multiple trials. These studies were applied in research contexts involving adolescents and young adults presenting with mild to moderate acne.

The research examined several core outcomes related to physical discomfort. Specifically, studies monitored and reported changes in the count of acne lesions, separating them into inflammatory types (papules and pustules) and non-inflammatory types (comedones). Trials also utilized overall disease assessment tools, such as the Investigator’s Global Assessment (IGA), to describe how symptoms evolved in the observed populations during the study period.

Comparative Study Landscape

Topical BPO monotherapy was also evaluated in studies comparing it against a non-active vehicle (placebo) to examine performance characteristics in conditions where symptoms may vary in intensity. Additionally, some trials explored how BPO was associated with outcomes when compared to other single-agent active topical treatments used for acne.

However, when comparing BPO to other single-agent active topical treatments, evidence is limited and heterogeneous across studies. Findings were mixed in some systematic reviews, and the reported outcomes for comparative performance often indicate low certainty. Data show patterns related to how different groups responded during these short-term studies, but the evidence quality varies, and comparative evidence is lacking in certain head-to-head scenarios.

Long-Term Studies and Follow-Up Data

The primary body of high-quality evidence, the RCTs used for regulatory review, focused almost exclusively on treatment periods up to 12 weeks. For this reason, follow-up durations were limited in the most certain research. This means that while studies were conducted during periods of increased symptom activity and explored short-term symptom changes, they provide limited insight into sustained management.

What Research Remains Uncertain or Limited

Research highlights what is known—and what is still uncertain. A key limitation noted by analysts is that the long-term effects are not fully established, and there is a knowledge gap regarding the durability of outcomes capturing phases of heightened symptom activity over many months. Additionally, the study populations primarily included adolescents and young adults with mild to moderate acne. Research exploring outcomes for individuals with very severe acne, older adults, or those with underlying systemic health conditions is limited, meaning the research does not provide insight into outcomes for individuals in these specific groups.

Key Studies & References

  1. Management of acne vulgaris: NICE Clinical Guideline
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Neutrogena Clear Pore (FAQ)


Q: Is Neutrogena Clear Pore a spot treatment or an all-over face wash?

According to the official product labeling, this preparation is intended for dual use. It can be used as a daily cleanser, applied all over the face, and also as an intensive face mask when left on for a short period of time.


Q: How quickly should I expect to see results from using Neutrogena Clear Pore?

Studies on the active ingredient, Benzoyl Peroxide, indicate that initial positive changes may start to become apparent after about four weeks of continuous application. Maximum effects have been observed after 8 to 12 weeks of continuous use in studies.


Q: Is it normal to feel a slight tingling sensation after using this product?

The product label mentions that common forms of irritation, such as stinging or burning sensations, may occur. If a slight tingling is experienced, this may be related to these common, localized reactions. If the sensation is severe, the official label instructs the user to stop use and ask a doctor.


Q: Can Neutrogena Clear Pore stain my towels or pillowcases?

Yes. The official labeling carries a specific warning that the product may bleach hair or colored fabrics, which can include towels, clothing, and bed linens. Care should be taken to ensure the product is thoroughly rinsed off and does not come into contact with colored materials.


Q: What should I do if my skin gets very red or irritated from Neutrogena Clear Pore?

Official directions advise that frequency of application should be reduced if bothersome skin effects like excessive drying or peeling occur. If irritation becomes severe, the official label instructs that the product should be stopped, and a doctor should be consulted.


Q: Can I use this product in the morning and at night?

The directions state that use should begin with one application daily. The frequency may then be increased gradually to two or three times a day, provided the product is well-tolerated.


Q: Why is hydration important when using products like Neutrogena Clear Pore?

Since the active ingredient, Benzoyl Peroxide, commonly causes skin dryness and peeling as a side effect, keeping your skin hydrated can help manage these effects. Common side effects like dryness may be managed with the application of a moisturizer.


Q: Does Neutrogena Clear Pore help with blackheads and whiteheads?

The product's marketing information states its use in clearing breakouts and impurities that cause blackheads. This aligns with the active ingredient's known action against pore blockages.


Q: Is Neutrogena Clear Pore effective for body acne as well as facial acne?

The official product directions specify its intended use on the face only. The product is not specifically directed for use on body areas.


Q: Will Neutrogena Clear Pore cause purging or an initial breakout?

Based on regulatory information for the active ingredient, acne symptoms have been noted to temporarily worsen during the first few weeks of treatment as the skin adjusts to the medication.


Q: Is this product suitable for oily skin, dry skin, or combination skin?

The official warning label does not provide recommendations for or against specific general skin types (oily, dry, or combination). However, the labeling advises against use on very sensitive, broken, cut, scraped, or sunburned skin.


Q: Does Neutrogena Clear Pore have an expiry date I need to look out for?

Yes. As an Over-the-Counter drug product, it is mandatory under government regulations for an expiration date to be clearly printed on the product's label or packaging.


Q: Do I need to leave the Neutrogena Clear Pore formula on my skin for a certain amount of time to work?

Usage instructions depend on the application method. When used as a face wash, it should be rinsed off thoroughly after gently massaging it into the skin. When used as a mask, it should be allowed to dry for a maximum of five minutes before rinsing.


Q: Why does Neutrogena Clear Pore sometimes have a strong scent?

The strong scent is likely due to the inclusion of 'Fragrance' in the inactive ingredients list of the product's formulation.


Q: Can I use Neutrogena Clear Pore if I am also using prescribed topical medication (non-specific)?

Official warnings advise caution when using it alongside another topical acne medication. If skin irritation and dryness occur in this scenario, official warnings advise limiting use to only one topical acne product at a time.


Q: Are there any reported cases of allergic reactions to Neutrogena Clear Pore?

While severe allergic reactions are considered rare, the product labeling includes a warning about the potential for severe systemic hypersensitivity reactions. The labeling instructs that the product should be stopped and a doctor consulted if severe irritation develops.


Q: Why does my skin feel tight after using Neutrogena Clear Pore?

Skin tightness is often related to dryness. Official safety information lists dryness as a common adverse reaction that can occur with the use of this product.


Q: Can using too much Neutrogena Clear Pore be harmful to my skin barrier?

The official label explicitly warns that excessive drying may occur. Frequency of application may need to be reduced if irritation or dryness becomes bothersome.


Q: What is the purpose of the cooling sensation people often describe?

The cooling sensation is due to the presence of Menthol in the list of inactive ingredients, which is a component known to provide a refreshing feel to the product.


Q: What kind of skin clearing benefits can I expect besides treating acne lesions?

The product is marketed for deep cleansing and providing extra shine control. This benefit is supported by its formulation, which helps to reduce excess surface sebum.

Advertisements

How should Neutrogena Clear Pore be stored and disposed of?

How to Store and Dispose of Neutrogena Clear Pore?

Official regulatory information outlines specific requirements for storing and handling Neutrogena Clear Pore to maintain product stability and safety. This product must be stored at Room Temperature.

Key storage and handling constraints defined by official labeling include:

Storage Constraint Requirement
Temperature Store at Room Temperature.
Safety & Access Keep out of reach of children.
Flammability Flammable: Keep away from fire or flame.

If this product is accidentally swallowed, immediate medical assistance is required. Contact a Poison Control Center or get medical help right away. These storage and handling rules are mandatory to ensure stability and mitigate risks associated with the product's formulation.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Neutrogena Clear Pore found in:

A-Z Index: